A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
NCT 04801095 Brief Summary This study evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics,…
Read more arrow_forwardNCT 04801095 Brief Summary This study evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics,…
Read more arrow_forwardNCT 05415072 Brief Summary This is a FIH, phase I/II, open…
Read more arrow_forwardNCT 06247995 Brief Summary In the phase I part, to determine the…
Read more arrow_forwardNCT 05123482 Brief Summary This research study is studying a new compound,…
Read more arrow_forwardNCT 06764875 Brief Summary This is a Phase Ⅲ, randomized, open-label, Sponsor-blinded,…
Read more arrow_forwardNCT 05182931 Brief Summary This prospective, multi-centre, open label, non-randomised phase II…
Read more arrow_forwardNCT 04923048 Brief Summary This is a Phase 1/2 study of GB261…
Read more arrow_forwardNCT 04923048 Brief Summary This is a Phase 1/2 study of GB261…
Read more arrow_forwardNCT 05332574 Brief Summary This is a Phase 1/2 study of GB263T…
Read more arrow_forwardNCT 06291220 Brief Summary Chronic lymphocytic leukemia (CLL) is the most common…
Read more arrow_forward